Difficulty: Medium
Average Score: 83%
Practice
Which of the following chemotherapeutic agents is classified as an alkylating agent?
Correct answer
D
Rationale
In the context of chemotherapy drugs, understanding the classification of alkylating agents is crucial for healthcare professionals. The correct answer is D) Cyclophosphamide and mechlorethamine. These drugs are classified as alkylating agents due to their mechanism of action, which involves adding alkyl groups to DNA strands, leading to DNA damage and ultimately cell death.
Option A) Cyclophosphamide is an alkylating agent, as mentioned above. It is used in the treatment of various cancers, including leukemia and lymphoma.
Option B) Etoposide is a topoisomerase inhibitor, not an alkylating agent. It works by disrupting DNA replication and is used in the treatment of lung cancer, testicular cancer, and other malignancies.
Option C) Mechlorethamine, also known as mustine, is another alkylating agent like cyclophosphamide. It is used in the treatment of Hodgkin's lymphoma, non-Hodgkin's lymphoma, and certain types of leukemia.
Understanding the classification of chemotherapeutic agents is vital for healthcare providers to select the most appropriate treatment regimens for patients and to monitor for potential side effects and drug interactions. Knowledge of drug classes and mechanisms of action enhances patient care and safety in the oncology setting, making this information essential for healthcare professionals working with cancer patients.
Option A) Cyclophosphamide is an alkylating agent, as mentioned above. It is used in the treatment of various cancers, including leukemia and lymphoma.
Option B) Etoposide is a topoisomerase inhibitor, not an alkylating agent. It works by disrupting DNA replication and is used in the treatment of lung cancer, testicular cancer, and other malignancies.
Option C) Mechlorethamine, also known as mustine, is another alkylating agent like cyclophosphamide. It is used in the treatment of Hodgkin's lymphoma, non-Hodgkin's lymphoma, and certain types of leukemia.
Understanding the classification of chemotherapeutic agents is vital for healthcare providers to select the most appropriate treatment regimens for patients and to monitor for potential side effects and drug interactions. Knowledge of drug classes and mechanisms of action enhances patient care and safety in the oncology setting, making this information essential for healthcare professionals working with cancer patients.